Allara Health – a virtual care platform bridging the care divide for women battling chronic hormonal conditions – announced a $26 million Series B funding round, bringing the company’s total funding to $38.5 million. Index Ventures led the funding round, and partner Martin Mignot will join Allara’s board. And existing investor GV (Google Ventures) also participated in the round. This Series B funding will enable Allara to bring specialized care to women nationwide struggling with hormonal conditions.
A large percentage of women will battle a chronic hormonal condition in their lifetimes, including polycystic ovarian syndrome (PCOS), endometriosis, and hypothyroidism – all of which can cause health challenges such as infertility, high-risk pregnancies, obesity, and diabetes. And for those struggling, receiving a diagnosis and finding supportive care can be difficult and it can take an average of ten years to receive an endometriosis diagnosis since most PCOS cases are undiagnosed.
Allara’s team of experts, such as OB-GYNs, endocrinologists, nurse practitioners, and Registered Dietitians, takes a whole-body approach to patient care, virtually delivering evidence-based solutions to help patients feel better faster. And for its thousands of patients nationwide, Allara offers expert-led care plans that combine medical expertise, lifestyle management, and community support – creating treatment programs personalized to individuals and their unique needs. Within a few weeks of treatment from Allara, over 75% of patients report feeling more in control of their health, empowered about their care, and hopeful about their outcomes.
Last year notable for Allara as the company grew by 4x, officially launched its care model across all 50 U.S. states, and forged new insurance partnerships with health plans, including Aetna, Blue Cross Blue Shield, Cigna, Humana, and United Healthcare. And Allara also invested in its clinical leadership, welcoming new Chief Medical Officer Dr. Heather Huddleston, a specialist in reproductive endocrinology and infertility and director of the UCSF PCOS Clinic and research program. Dr. Huddleston will deepen Allara’s established clinical expertise and lead forays into new areas of care in the coming years.
KEY QUOTES:
“Allara was built for the tens of millions of women living with complex hormonal and gynecologic conditions across the U.S., myself included. After receiving a PCOS diagnosis without sufficient medical support, I realized firsthand the inequities that exist for many of us throughout the healthcare system. At Allara, we ensure women struggling with hormonal conditions can access affordable care that answers questions, minimizes symptoms, and helps them live fulfilling lives – and we are incredibly grateful for the support from our investors as we deliver on this mission.”
- Founder and CEO Rachel Blank
“The challenges that women face in healthcare have been overlooked and underappreciated for too long. Allara has created a new way for women to engage with specialty care: personalized treatment delivered at scale by a team of experts who care deeply about their patients. As the healthcare market makes the jump from offline to online – similar to what we saw with consumer internet 20 years ago – there’s a significant opportunity to provide better access to care for patients and better quality of life for providers.”
- Martin Mingot, Partner at Index Ventures
